The test strips market size has grown steadily in recent years. It will grow from $68.13 billion in 2025 to $71.42 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to limited availability of home-testing kits, reliance on traditional laboratory diagnostics, increasing prevalence of diabetes, growing awareness of early disease detection, constrained distribution channels.
The test strips market size is expected to see steady growth in the next few years. It will grow to $85.21 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to technological advancements in biosensors, rising adoption of digital health platforms, expansion of hospital and homecare services, growing prevalence of chronic diseases, integration with AI-powered diagnostic tools. Major trends in the forecast period include rising adoption of home-based testing solutions, increasing demand for multi-parameter test strips, integration with mobile health applications, expansion of point-of-care diagnostic testing, growing focus on rapid and accurate detection.
The increasing prevalence of diabetes is expected to propel the growth of the test strips market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The rise in diabetes cases is largely attributed to sedentary lifestyles, as a lack of physical activity contributes to weight gain and reduced insulin sensitivity, both of which increase the risk of developing the disease. Test strips support diabetes management by offering quick and accurate blood glucose readings, making daily monitoring more effective and convenient. They provide a simple way to track blood sugar levels, facilitating timely treatment decisions and improving overall health outcomes. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% increase from 3,065,825 cases in 2022. As a result, the rising prevalence of diabetes is driving growth in the test strips market.
Major companies operating in the test strip market are focusing on the development of advanced products, such as drug detection test strips, to improve detection capabilities, user experience, and accuracy. Drug detection test strips are compact, portable devices designed to rapidly identify the presence of specific drugs or their metabolites in biological samples like urine or saliva. For example, in September 2024, Greenlane Holdings Inc., a US-based cannabis accessories distributor, introduced test strips for detecting fentaNYL, Xylazine, and drink-spiking substances such as benzodiazepines and ketamine. These advanced tools are designed to provide highly sensitive and accurate results within two minutes. Featuring a user-friendly dip-and-read or drop-and-wait format with clear visual indicators, the strips are disposable and easy to use, making them suitable for use in bars, nightclubs, festivals, and personal safety kits.
In February 2025, Safe Supply Streaming Co. Ltd., a Canada-based medical company, acquired Safety Strips Tech Corp. for an undisclosed amount. This acquisition aims to expand Safe Supply Streaming’s product offerings in the diagnostic test strips market, enhance its technological capabilities, and strengthen its presence in key global regions. Safety Strips Tech Corp. is a US-based company specializing in diagnostic test strips for medical use.
Major companies operating in the test strips market are Johnson & Johnson, F Hoffmann La Roche Ltd, Abbott Laboratories, Abbott Diabetes Care, Siemens Healthcare GmbH, Becton Dickinson and Company, bioMerieux SA, Bio Rad Laboratories Inc, TaiDoc Technology Corporation, Macherey Nagel GmbH and Co KG, OneTouch, EKF Diagnostics Holdings plc, Bionime Corporation, ACON Laboratories Inc, i SENS Inc, BTNX Inc, ARKRAY Inc, Ascensia Diabetes Care, LifeScan Inc, Nova Biomedical, Trividia Health, Nipro Diagnostics.
North America was the largest region in the test strips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the test strips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the test strips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the test strips market by increasing the cost of imported raw materials, reagents, and sensor components, leading to higher production expenses. Segments like blood glucose and multi-parameter test strips are most impacted, with Asia-Pacific regions such as China and India facing significant import duties. While tariffs have created cost pressures and disrupted supply chains, they have also encouraged local manufacturing, innovation in production methods, and investment in domestic diagnostic technology capabilities.
The test strips market research report is one of a series of new reports that provides test strips market statistics, including test strips industry global market size, regional shares, competitors with a test strips market share, detailed test strips market segments, market trends and opportunities, and any further data you may need to thrive in the test strips industry. This test strips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Test strips are compact, disposable tools coated with chemical agents that interact with specific substances found in liquid samples like blood or urine. They are primarily used to deliver fast, convenient, and on-the-spot analysis or measurement of various analytes, assisting in health monitoring or contaminant detection.
The main categories of test strips include blood test strips, urine test strips, and others. Blood test strips are narrow, lightweight devices intended to identify certain chemicals or substances in a small blood sample. These products are distributed through multiple channels, such as online and offline retail, direct sales, hospital procurement networks, and dedicated distributors. Test strips are utilized in numerous applications, including diabetes monitoring, infectious disease screening, cardiac biomarker testing, pregnancy and fertility detection, among others. They serve a wide range of end users like hospitals and clinics, homecare settings, diagnostic laboratories, and more.
The test strips market consists of sales of glucose test strips, pH test strips, ketone test strips, cholesterol test strips, and drug-of-abuse test strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The test strips market size is expected to see steady growth in the next few years. It will grow to $85.21 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to technological advancements in biosensors, rising adoption of digital health platforms, expansion of hospital and homecare services, growing prevalence of chronic diseases, integration with AI-powered diagnostic tools. Major trends in the forecast period include rising adoption of home-based testing solutions, increasing demand for multi-parameter test strips, integration with mobile health applications, expansion of point-of-care diagnostic testing, growing focus on rapid and accurate detection.
The increasing prevalence of diabetes is expected to propel the growth of the test strips market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The rise in diabetes cases is largely attributed to sedentary lifestyles, as a lack of physical activity contributes to weight gain and reduced insulin sensitivity, both of which increase the risk of developing the disease. Test strips support diabetes management by offering quick and accurate blood glucose readings, making daily monitoring more effective and convenient. They provide a simple way to track blood sugar levels, facilitating timely treatment decisions and improving overall health outcomes. For example, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, reflecting an 18% increase from 3,065,825 cases in 2022. As a result, the rising prevalence of diabetes is driving growth in the test strips market.
Major companies operating in the test strip market are focusing on the development of advanced products, such as drug detection test strips, to improve detection capabilities, user experience, and accuracy. Drug detection test strips are compact, portable devices designed to rapidly identify the presence of specific drugs or their metabolites in biological samples like urine or saliva. For example, in September 2024, Greenlane Holdings Inc., a US-based cannabis accessories distributor, introduced test strips for detecting fentaNYL, Xylazine, and drink-spiking substances such as benzodiazepines and ketamine. These advanced tools are designed to provide highly sensitive and accurate results within two minutes. Featuring a user-friendly dip-and-read or drop-and-wait format with clear visual indicators, the strips are disposable and easy to use, making them suitable for use in bars, nightclubs, festivals, and personal safety kits.
In February 2025, Safe Supply Streaming Co. Ltd., a Canada-based medical company, acquired Safety Strips Tech Corp. for an undisclosed amount. This acquisition aims to expand Safe Supply Streaming’s product offerings in the diagnostic test strips market, enhance its technological capabilities, and strengthen its presence in key global regions. Safety Strips Tech Corp. is a US-based company specializing in diagnostic test strips for medical use.
Major companies operating in the test strips market are Johnson & Johnson, F Hoffmann La Roche Ltd, Abbott Laboratories, Abbott Diabetes Care, Siemens Healthcare GmbH, Becton Dickinson and Company, bioMerieux SA, Bio Rad Laboratories Inc, TaiDoc Technology Corporation, Macherey Nagel GmbH and Co KG, OneTouch, EKF Diagnostics Holdings plc, Bionime Corporation, ACON Laboratories Inc, i SENS Inc, BTNX Inc, ARKRAY Inc, Ascensia Diabetes Care, LifeScan Inc, Nova Biomedical, Trividia Health, Nipro Diagnostics.
North America was the largest region in the test strips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the test strips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the test strips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the test strips market by increasing the cost of imported raw materials, reagents, and sensor components, leading to higher production expenses. Segments like blood glucose and multi-parameter test strips are most impacted, with Asia-Pacific regions such as China and India facing significant import duties. While tariffs have created cost pressures and disrupted supply chains, they have also encouraged local manufacturing, innovation in production methods, and investment in domestic diagnostic technology capabilities.
The test strips market research report is one of a series of new reports that provides test strips market statistics, including test strips industry global market size, regional shares, competitors with a test strips market share, detailed test strips market segments, market trends and opportunities, and any further data you may need to thrive in the test strips industry. This test strips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Test strips are compact, disposable tools coated with chemical agents that interact with specific substances found in liquid samples like blood or urine. They are primarily used to deliver fast, convenient, and on-the-spot analysis or measurement of various analytes, assisting in health monitoring or contaminant detection.
The main categories of test strips include blood test strips, urine test strips, and others. Blood test strips are narrow, lightweight devices intended to identify certain chemicals or substances in a small blood sample. These products are distributed through multiple channels, such as online and offline retail, direct sales, hospital procurement networks, and dedicated distributors. Test strips are utilized in numerous applications, including diabetes monitoring, infectious disease screening, cardiac biomarker testing, pregnancy and fertility detection, among others. They serve a wide range of end users like hospitals and clinics, homecare settings, diagnostic laboratories, and more.
The test strips market consists of sales of glucose test strips, pH test strips, ketone test strips, cholesterol test strips, and drug-of-abuse test strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Test Strips Market Characteristics
3. Test Strips Market Supply Chain Analysis
4. Global Test Strips Market Trends and Strategies
5. Test Strips Market Analysis of End Use Industries
7. Global Test Strips Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Test Strips Total Addressable Market (TAM) Analysis for the Market
9. Test Strips Market Segmentation
10. Test Strips Market Regional and Country Analysis
11. Asia-Pacific Test Strips Market
12. China Test Strips Market
13. India Test Strips Market
14. Japan Test Strips Market
15. Australia Test Strips Market
16. Indonesia Test Strips Market
17. South Korea Test Strips Market
18. Taiwan Test Strips Market
19. South East Asia Test Strips Market
20. Western Europe Test Strips Market
21. UK Test Strips Market
22. Germany Test Strips Market
23. France Test Strips Market
24. Italy Test Strips Market
25. Spain Test Strips Market
26. Eastern Europe Test Strips Market
27. Russia Test Strips Market
28. North America Test Strips Market
29. USA Test Strips Market
30. Canada Test Strips Market
31. South America Test Strips Market
32. Brazil Test Strips Market
33. Middle East Test Strips Market
34. Africa Test Strips Market
36. Test Strips Market Competitive Landscape and Company Profiles
37. Test Strips Market Other Major and Innovative Companies
40. Test Strips Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Test Strips Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses test strips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for test strips? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The test strips market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Blood Test Strips; Urine Test Strips; Other Product Types2) By Distribution Channel: Online Retail; Offline Retail; Direct Sales; Hospital Supply Chains; Specialized Distributors
3) By Application: Diabetes; Infectious Disease; Cardiac Marker Testing; Pregnancy And Fertility Testing; Other Applications
4) By End User: Hospitals And Clinics; Homecare; Diagnostic Labs; Other End Users
Subsegments:
1) By Blood Test Strips: Glucose Test Strips; Cholesterol Test Strips; Hemoglobin Test Strips; Ketone Test Strips; Coagulation Test Strips2) By Urine Test Strips: pH Test Strips; Protein Test Strips; Glucose Test Strips; Ketone Test Strips; Leukocyte And Nitrite Test Strips; Specific Gravity Test Strips; Microalbumin Test Strips
3) By Other Product Types: Saliva Test Strips; Sweat Test Strips; Multi-Parameter Test Strips; Drug of Abuse Test Strips; Fertility Or Pregnancy Test Strips
Companies Mentioned: Johnson & Johnson; F Hoffmann La Roche Ltd; Abbott Laboratories; Abbott Diabetes Care; Siemens Healthcare GmbH; Becton Dickinson and Company; bioMerieux SA; Bio Rad Laboratories Inc; TaiDoc Technology Corporation; Macherey Nagel GmbH and Co KG; OneTouch; EKF Diagnostics Holdings plc; Bionime Corporation; ACON Laboratories Inc; i SENS Inc; BTNX Inc; ARKRAY Inc; Ascensia Diabetes Care; LifeScan Inc; Nova Biomedical; Trividia Health; Nipro Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Test Strips market report include:- Johnson & Johnson
- F Hoffmann La Roche Ltd
- Abbott Laboratories
- Abbott Diabetes Care
- Siemens Healthcare GmbH
- Becton Dickinson and Company
- bioMerieux SA
- Bio Rad Laboratories Inc
- TaiDoc Technology Corporation
- Macherey Nagel GmbH and Co KG
- OneTouch
- EKF Diagnostics Holdings plc
- Bionime Corporation
- ACON Laboratories Inc
- i SENS Inc
- BTNX Inc
- ARKRAY Inc
- Ascensia Diabetes Care
- LifeScan Inc
- Nova Biomedical
- Trividia Health
- Nipro Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 71.42 Billion |
| Forecasted Market Value ( USD | $ 85.21 Billion |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
